Eliquis 2.5 Mg – Apixaban

What Is Eliquis 2.5 Mg – Apixaban?

Eliquis 2.5 Mg – Apixaban is an oral prescription anticoagulant (blood thinner) medication. It is indicated to help reduce the risk of:

• Stroke and systemic embolism in adults with non-valvular atrial fibrillation

• Recurrence of deep vein thrombosis (DVT) and pulmonary embolism (PE)

• DVT and PE following hip or knee replacement surgery

Apixaban belongs to a class of medicines called direct oral anticoagulants (DOACs). It works by selectively inhibiting Factor Xa, a key enzyme in the blood coagulation cascade that leads to clot formation.

This prescription medicine should be used under the direction of a qualified healthcare provider.

How Eliquis (Apixaban) Works

1. Direct Factor Xa Inhibition

Apixaban selectively blocks Factor Xa, an essential enzyme in the coagulation cascade responsible for converting prothrombin into thrombin, which subsequently forms fibrin clots.

2. Reduces Thrombin Generation

By inhibiting Factor Xa, apixaban decreases thrombin production and limits clot formation.

3. Predictable Anticoagulant Effect

Unlike older anticoagulants such as warfarin, apixaban has more predictable effects and usually does not require routine blood monitoring of INR in most patients, unless clinically indicated.

Mineralocorticoid receptor–based cardiovascular strategies may include Eplerenone Tablets 25 Mg within long-term care planning.

Indications

A qualified clinician may prescribe Eliquis 2.5 Mg for:

• Prevention of stroke and systemic embolism in non-valvular atrial fibrillation

• Treatment of DVT and PE

• Prevention of recurrent DVT and PE

• Reduction of DVT and PE risk after hip or knee replacement surgery

Indications are determined by medical history and individual risk profiles.

Dosage & Administration

⚠ Always follow your healthcare provider’s prescription.

• Usually taken twice daily

• May be taken with or without food

• Swallow tablets whole with water

• Do not crush or chew

Missed dose:
Take as soon as you remember on the same day. Do not double the next dose.

Proper inhaler technique and treatment adherence follow standardized guidance used in national healthcare systems such as the NHS.

Clinical Benefits

When used according to professional guidance:

• Helps reduce the risk of stroke associated with atrial fibrillation

• Prevents clot recurrence after initial DVT/PE therapy

• Supports thrombosis prevention after orthopedic surgery

• Offers reliable anticoagulation with predictable pharmacokinetics

Individual benefits vary based on clinical context and concurrent conditions.

Structured cardiovascular therapy models may incorporate Eplerenone Tablets 50 Mg as part of integrated treatment planning.

Safety Information & Precautions

Before using this medication, inform your healthcare provider if you have:

• Active bleeding

• History of bleeding disorders

• Severe liver or kidney disease

• Brain hemorrhage history

• Recent major surgery

• Use of other anticoagulants or antiplatelet drugs

Important Safety Notes

• Increased risk of bleeding is the most significant risk

• Do not stop therapy without clinician approval — abrupt cessation may increase clot risk

• Inform your clinician before surgeries or dental procedures

Possible Side Effects

Common side effects may include:

• Bruising more easily than normal

• Nosebleeds

• Minor bleeding from gums

• Prolonged bleeding from cuts

• Gastrointestinal discomfort

Seek urgent medical attention for:

• Blood in urine or stool

• Coughing up blood

• Severe headache or weakness

• Uncontrolled bleeding

This list is not exhaustive — always consult a healthcare professional.

Drug Interactions

Inform your clinician about all medications and supplements you are taking, including:

• Other anticoagulants or antiplatelet drugs

• NSAIDs

• Certain antifungals and antibiotics

• Herbal supplements such as St. John’s Wort

Interactions may increase bleeding risk or affect drug efficacy.

Use in Special Populations

Pregnancy and Breastfeeding

Discuss with your healthcare provider before use. Use during pregnancy should be considered only if clearly needed.

Elderly Patients

Older adults may have increased sensitivity to bleeding risks — close clinical monitoring may be advised.

Renal or Hepatic Impairment

Dosage adjustments and evaluation of kidney and liver function may be needed.

Monitoring and Follow-Up

Although routine INR monitoring is usually not required, a clinician may:

• Check kidney and liver function

• Monitor for signs of bleeding

• Adjust dosage based on clinical response

Regular follow-up improves treatment safety and effectiveness.

Storage Instructions

• Store tablets in a cool, dry place below 25 °C

• Keep in the original container

• Protect from moisture and direct sunlight

• Keep out of reach of children

• Do not use past the expiry date

  FAQs